InvestorsHub Logo
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Wednesday, 10/22/2014 6:01:55 AM

Wednesday, October 22, 2014 6:01:55 AM

Post# of 18784
Haukeland University Hospital (Norway) added to the list for Study Comparing AEZS-108/ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) to Doxorubicin as a Second Line Therapy of Endometrial Cancer.

The more the better for visibility.
http://clinicaltrials.gov/archive/NCT01767155/2014_10_19/changes


Getting closer to our 5 Nov PDUFA for Macrilen™
Evaluation of adult growth hormone deficiency (endocrinology)

smile

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News